Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Medische/verpleegkundige diensten”
Aandelen in “Medische/verpleegkundige diensten”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Geen effecten gevonden.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Medische/verpleegkundige diensten”
Toon enkel gratis nieuws
2/11 ·
What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
· Persbericht
2/11 ·
What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
· Persbericht
29/10 ·
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law
· Persbericht
29/10 ·
DaVita Inc. 3rd Quarter 2026 Results
· Persbericht
28/10 ·
Castle Biosciences to Participate in Upcoming Investor Conferences
· Persbericht
27/10 ·
DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
· Persbericht
27/10 ·
ENSG Investor Class Action Filed: Ensign Group Investors Are Alerted to the Upcoming December 7 Deadline in the Securities Fraud Class Action to Recover Losses
· Persbericht
26/10 ·
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law
· Persbericht
26/10 ·
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law
· Persbericht
22/10 ·
Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™
· Persbericht
21/10 ·
DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice
· Persbericht
20/10 ·
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
· Persbericht
20/10 ·
Shareholders who lost money in shares of The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately
· Persbericht
20/10 ·
What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
· Persbericht
19/10 ·
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
· Persbericht
19/10 ·
RAMSAY GENERALE DE SANTE : Availability of the 2026 URD - Evolution in the Governance - Annual General meeting on 4th December 2026
· Persbericht
19/10 ·
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
· Persbericht
15/10 ·
Shareholders who lost money in shares of acquired The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately
· Persbericht
15/10 ·
Shareholders who lost money in shares of The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately
· Persbericht
15/10 ·
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
· Persbericht
15/10 ·
Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe